World Wires · story 27707 · unverified · 1 source(s)

Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes

Company announcement – No. 54 / 2026

Open in the desk

Coverage

• Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes GlobeNewswire: public companies · tier D · clear net · 2026-10-07 17:14 UTC

What this site indexes